Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)

for
Advanced Solid Tumors, Malignant Neoplasm
Location: San Antonio TX
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07785609

Phase 2, Recruiting

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

for
Cardiac Conditions, Connective Tissue Diseases, Retinal Disease,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT06455384

Recruiting

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT04926467

Phase 2, Recruiting

Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study

for
Cancer
Location: Washington D.C. DC
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18+

Code: NCT07228377

Recruiting

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

for
Small Cell Lung Cancer Extensive Stage, Brain Metastases,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07139990

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07226154

Recruiting

The Gut Microbiome and Immunotherapy Response in Solid Cancers

for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 35 - 70+

Code: NCT06050733

Recruiting

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for
Breast Cancer, Advanced Solid Tumor
Location: New Haven CT, Birmingham AL, St Louis MO, Houston TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07222267

Phase 1, Recruiting

Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies

for
Solid Tumor Malignancies
Location: Westwood KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07174453

Phase 3, Recruiting

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

for
Advanced Solid Tumor
Location: Port Huron MI, Macomb MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07098299

Phase 1, Recruiting

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

for
Cancer, Oncology
Location: Hilo HI, Honolulu HI, Lihue HI
Sponsor: University of Hawaii

Sex: All

Age: 18+

Code: NCT06237816

Recruiting

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

for
Neoplasms
Location: New Hyde Park NY, Toronto, Philadelphia PA, Ottawa,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07277270

Phase 1, Recruiting

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07232043

Recruiting

Testing a WearabLE Artificial Intelligence-POwered Device For OPtimal DAily RaDiation Therapy Using Image Guidance

for
Pelvic Malignancies
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT06820385

Recruiting

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

for
Pancreatic Ductal Adenocarcinoma (PDAC), Hand Grip Strength
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT07255001

Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

for
Multiple Myeloma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06251076

Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

for
Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor,
Location: Montreal, Toronto, Vancouver
Sponsor: Australian & New Zealand Children's Haematology/Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06208657

Phase 1, Phase 2, Recruiting

Modafinil to Improve Fatiguability

for
Cancer-related Cognitive Difficulties,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05333250

Phase 1, Phase 2, Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Lake Success NY, Fairfax VA, Nashville TN
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07730021

Phase 1, Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial